[go: up one dir, main page]

AU2001264950A1 - Methods of screening for parkinson's disease - Google Patents

Methods of screening for parkinson's disease

Info

Publication number
AU2001264950A1
AU2001264950A1 AU2001264950A AU6495001A AU2001264950A1 AU 2001264950 A1 AU2001264950 A1 AU 2001264950A1 AU 2001264950 A AU2001264950 A AU 2001264950A AU 6495001 A AU6495001 A AU 6495001A AU 2001264950 A1 AU2001264950 A1 AU 2001264950A1
Authority
AU
Australia
Prior art keywords
parkinson
screening
disease
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264950A
Inventor
Margaret A. Pericak-Vance
William K. Scott
Jeffrey M. Stajich
Jeffery M. Vance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of AU2001264950A1 publication Critical patent/AU2001264950A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001264950A 2000-05-26 2001-05-24 Methods of screening for parkinson's disease Abandoned AU2001264950A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US20810200P 2000-05-26 2000-05-26
US60208102 2000-05-26
US23807800P 2000-10-04 2000-10-04
US60238078 2000-10-04
US28196501P 2001-04-06 2001-04-06
US60281965 2001-04-06
PCT/US2001/016940 WO2001092576A1 (en) 2000-05-26 2001-05-24 Methods of screening for parkinson's disease

Publications (1)

Publication Number Publication Date
AU2001264950A1 true AU2001264950A1 (en) 2001-12-11

Family

ID=27395152

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264950A Abandoned AU2001264950A1 (en) 2000-05-26 2001-05-24 Methods of screening for parkinson's disease

Country Status (3)

Country Link
US (1) US20040248092A1 (en)
AU (1) AU2001264950A1 (en)
WO (1) WO2001092576A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002000A2 (en) * 2000-06-30 2002-01-10 Duke University Methods of screening for alzheimer's disease
AU2002339230A1 (en) * 2002-03-08 2003-09-22 Decode Genetics Ehf. A susceptibility gene for late-onset idiopathic parkinson's disease
US20040014109A1 (en) * 2002-05-23 2004-01-22 Pericak-Vance Margaret A. Methods and genes associated with screening assays for age at onset and common neurodegenerative diseases
US20060183117A1 (en) * 2002-07-08 2006-08-17 Pericak-Vance Margaret A Screening for alzheimer's disease
US7680086B2 (en) * 2002-09-09 2010-03-16 Siemens Canada Limited Wireless local area network with clients having extended freedom of movement
US20060246437A1 (en) * 2003-07-11 2006-11-02 Pericak-Vance Margaret A Genetic susceptibility genes for asthma and atopy and asthma-related and atopic-related phenotypes
US20060068428A1 (en) * 2003-11-03 2006-03-30 Duke University Identification of genetic markers associated with parkinson disease
US20050191652A1 (en) * 2003-11-03 2005-09-01 Vance Jeffery M. Identification of genetic forms of a gene that leads to high risk for parkinson disease
DE102004004924B4 (en) * 2004-01-27 2007-04-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum A141S and G399S mutation in the Omi / HtrA2 protein in Parkinson's disease
US7790390B2 (en) * 2004-10-27 2010-09-07 Duke University Methods for identifying an individual at increased risk of developing coronary artery disease
US7807465B2 (en) 2004-10-27 2010-10-05 Duke University Methods for identifying an individual at increased risk of developing coronary artery disease
US20070148661A1 (en) * 2005-07-19 2007-06-28 Duke University LSAMP Gene Associated With Cardiovascular Disease
US20090226420A1 (en) * 2005-11-10 2009-09-10 Elizabeth Hauser Methods of Determining the Risk of Developing Coronary Artery Disease
WO2009152521A2 (en) * 2008-06-13 2009-12-17 Parkinson's Institute Diagnosis of neurodegenerative disorders
FR2935712A1 (en) * 2008-09-05 2010-03-12 Ct Hospitalier Regional Univer METHOD FOR DETECTING THE DIFFERENTIAL EXPRESSION OF A MOLECULAR MARK SET ASSOCIATED WITH PARKINSON'S DISEASE
GB201209689D0 (en) * 2012-05-31 2012-07-18 Imp Innovations Ltd Methods
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
KR102465122B1 (en) 2016-02-12 2022-11-09 리제너론 파마슈티칼스 인코포레이티드 Methods and systems for detection of abnormal karyotypes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374525A (en) * 1992-09-30 1994-12-20 University Of Utah Research Foundation Methods to determine predisposition to hypertension and association of variant angiotensinogen gene and hypertension
CA2142300C (en) * 1992-10-13 2005-08-23 Allen D. Roses Methods for detecting alzheimer's disease
US5449604A (en) * 1992-10-21 1995-09-12 University Of Washington Chromosome 14 and familial Alzheimers disease genetic markers and assays
US5879884A (en) * 1994-12-29 1999-03-09 Peroutka; Stephen J. Diagnosis of depression by linkage of a polymorphic marker to a segment of chromosome 19P13 bordered by D19S247 and D19S394
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
US5958684A (en) * 1995-10-02 1999-09-28 Van Leeuwen; Frederik Willem Diagnosis of neurodegenerative disease
US6108635A (en) * 1996-05-22 2000-08-22 Interleukin Genetics, Inc. Integrated disease information system
US5922556A (en) * 1997-07-03 1999-07-13 The Trustees Of Columbia University In The City Of New York Parkinson's disease tests
US6342350B1 (en) * 1997-09-05 2002-01-29 The General Hospital Corporation Alpha-2-macroglobulin diagnostic test
WO1999057129A1 (en) * 1998-05-01 1999-11-11 Mayo Foundation For Medical Education And Research Pathogeniv tau mutations
DE69941300D1 (en) * 1998-11-19 2009-10-01 Aventis Pharma Sa DRIVING AND USE
US20020037508A1 (en) * 2000-01-19 2002-03-28 Michele Cargill Human single nucleotide polymorphisms
WO2002002000A2 (en) * 2000-06-30 2002-01-10 Duke University Methods of screening for alzheimer's disease
US20040014109A1 (en) * 2002-05-23 2004-01-22 Pericak-Vance Margaret A. Methods and genes associated with screening assays for age at onset and common neurodegenerative diseases
US20060068428A1 (en) * 2003-11-03 2006-03-30 Duke University Identification of genetic markers associated with parkinson disease
US20050191652A1 (en) * 2003-11-03 2005-09-01 Vance Jeffery M. Identification of genetic forms of a gene that leads to high risk for parkinson disease

Also Published As

Publication number Publication date
WO2001092576A1 (en) 2001-12-06
US20040248092A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
AU2001264950A1 (en) Methods of screening for parkinson's disease
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2002219824A1 (en) Compositions and methods for diagnosing alzheimer's disease
AU2557500A (en) Methods of making compounds
AU2865000A (en) Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
AU2002319615A1 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
AU2003253621A1 (en) Modified "s" antibodies
AU2001273661A1 (en) Methods of screening for alzheimer's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2002239765A1 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
AU2002246490A1 (en) Method of treating parkinson's disease
AU2003254146A1 (en) Methods for the treatment of parkinson's disease
AU8182098A (en) Parkinson's disease tests
AU2003298178A1 (en) Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea
AU2002341044A1 (en) Methods for detecting parkinson's disease
AUPR202400A0 (en) Method of screening for inhibitors of alzheimer's disease
AU2003251962A1 (en) Screening for alzheimer's disease
AU2002242348A1 (en) Process for obtaining 3'-epilutein
IL162770A0 (en) Process for the preparation methylsteroids of 7
AU2001220139A1 (en) System for analysing people's movements
AU2001273675A1 (en) Methods and assays for diagnosing alzheimer's disease
AU2003216696A1 (en) Methods for the selection of compounds useful for the treatment of huntington's disease
AU2002331051A1 (en) An animal model for parkinson's disease
AU2002248511A1 (en) Methods of screening for disease
AU2001258569A1 (en) Alzheimer's disease assay